- Home
- UTHR vs JHX Comparison
UTHR vs JHX Comparison
Compare UTHR & JHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- JHX
- Stock Information
- Founded
- UTHR 1996
- JHX 1888
- Country
- UTHR United States
- JHX Ireland
- Employees
- UTHR N/A
- JHX N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- JHX Building Materials
- Sector
- UTHR Health Care
- JHX Industrials
- Exchange
- UTHR Nasdaq
- JHX Nasdaq
- Market Cap
- UTHR 15.5B
- JHX 13.4B
- IPO Year
- UTHR 1999
- JHX N/A
- Fundamental
- Price
- UTHR $364.00
- JHX $35.38
- Analyst Decision
- UTHR Buy
- JHX Hold
- Analyst Count
- UTHR 14
- JHX 3
- Target Price
- UTHR $370.86
- JHX N/A
- AVG Volume (30 Days)
- UTHR 371.2K
- JHX 73.0K
- Earning Date
- UTHR 10-30-2024
- JHX 11-12-2024
- Dividend Yield
- UTHR N/A
- JHX N/A
- EPS Growth
- UTHR 25.10
- JHX N/A
- EPS
- UTHR 22.72
- JHX 1.01
- Revenue
- UTHR $2,756,200,000.00
- JHX $3,935,900,000.00
- Revenue This Year
- UTHR $26.32
- JHX $1.87
- Revenue Next Year
- UTHR $10.37
- JHX $10.17
- P/E Ratio
- UTHR $16.00
- JHX $34.76
- Revenue Growth
- UTHR 25.04
- JHX 5.47
- 52 Week Low
- UTHR $208.62
- JHX $29.88
- 52 Week High
- UTHR $417.82
- JHX $43.57
- Technical
- Relative Strength Index (RSI)
- UTHR 44.48
- JHX 55.81
- Support Level
- UTHR $353.65
- JHX $35.07
- Resistance Level
- UTHR $417.82
- JHX $36.12
- Average True Range (ATR)
- UTHR 11.21
- JHX 0.97
- MACD
- UTHR -4.22
- JHX 0.54
- Stochastic Oscillator
- UTHR 16.64
- JHX 81.05
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About JHX James Hardie Industries plc (Ireland)
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.